Inventor · disambiguated record
Hussien Al-Shamma
Also filed as: AL-SHAMMA HUSSIEN A
13 granted patents·7 pending applications·143 citations·filing 2000–2009
92Inventor score
Top patents by PatentIndex Score
20 records- 0190US6765013B2Thiazolidinedione derivatives for the treatment of diabetes and other diseasesINCYTE SAN DIEGO·Filed 2002·Granted Jul 20, 2004·37 cites·32 claims
- 0289US6515003B1Heterocyclic derivatives for the treatment of diabetes and other diseasesMAXIA PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·42 cites·23 claims
- 0387US7803753B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·6 cites·11 claims
- 0485US8198232B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelCHU ZHI-LIANG·Filed 2009·Granted Jun 12, 2012·5 cites·66 claims
- 0581US8030270B2Methods for identifying GLP-1 secretagoguesARENA PHARM INC·Filed 2009·Granted Oct 4, 2011·2 cites·9 claims
- 0681US8022034B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2009·Granted Sep 20, 2011·2 cites·34 claims
- 0780US7803754B2Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelARENA PHARM INC·Filed 2006·Granted Sep 28, 2010·2 cites·24 claims
- 0880US7226940B2Substituted heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2005·Granted Jun 5, 2007·3 cites·20 claims
- 0978US7153875B2Heterocyclic derivatives for the treatment of cancer and other proliferative diseasesINCYTE SAN DIEGO·Filed 2002·Granted Dec 26, 2006·13 cites·9 claims
- 1078US7102000B2Heterocyclic amide derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Sep 5, 2006·9 cites·77 claims
- 1177US7071218B2N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·10 cites·45 claims
- 1274US6974826B2Imidazolidinedione derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2004·Granted Dec 13, 2005·5 cites·32 claims
- 1371US7196108B2Bicyclic heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Mar 27, 2007·7 cites·61 claims
- 1459US2006154866A1Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 levelCHU ZHI-LIANG·Filed 2006·Application pending·0 cites
- 1550US2006160796A1N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1648US2006241138A1Heterocyclic amide derivatives for the treatment of diabetes and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1747US2005209286A1RXR activating moleculesPFAHL MAGNUS·Filed 2005·Application pending·0 cites
- 1842US2005038098A1Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseasesFiled 2004·Application pending·0 cites
- 1942US2003083357A1Oxime derivatives for the treatment of dyslipidemia and hypercholesteremiaFiled 2002·Application pending·0 cites
- 2038US2004097566A12-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancerFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hussien Al-Shamma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →